Last reviewed · How we verify
FLU-v
FLU-v is an inactivated influenza vaccine.
FLU-v is an inactivated influenza vaccine. Used for Influenza prevention.
At a glance
| Generic name | FLU-v |
|---|---|
| Sponsor | PepTcell Limited |
| Drug class | inactivated vaccine |
| Modality | Biologic |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 2 |
Mechanism of action
It works by introducing a small, harmless piece of the influenza virus to the body, which triggers an immune response and helps protect against future infections.
Approved indications
- Influenza prevention
Common side effects
- Pain, redness, or swelling at the injection site
Key clinical trials
- Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses (NA)
- Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women (PHASE2)
- Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases (HAV-RID Study) (NA)
- Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. (PHASE4)
- First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults (PHASE1)
- Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years
- A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A (PHASE2)
- Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FLU-v CI brief — competitive landscape report
- FLU-v updates RSS · CI watch RSS
- PepTcell Limited portfolio CI